CAREDX, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
CAREDX, INC. (CDNA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $26.69 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-07-30
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2026-03-31 was $27.68, a 33.27% decline year-over-year.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $41.48, a 36.18% increase year-over-year.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $30.46, a 9.91% decline year-over-year.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $33.81, a 2.15% increase year-over-year.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $37.70, a 38.65% increase from fiscal 2024.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $27.19, a 0.22% increase from fiscal 2023.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $27.13, a 20.11% decline from fiscal 2022.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $33.96, a 32.09% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.69 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | $27.68 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | $37.70 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $39.39 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | $41.76 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | $41.48 10-Q · filed 2025-04-30 | |||
| 2024-12-31 | $27.19 10-K · filed 2025-02-28 | |||
| 2024-09-30 | $31.98 10-Q · filed 2024-11-04 | |||
| 2024-06-30 | $30.19 10-Q · filed 2024-07-31 | |||
| 2024-03-31 | $30.46 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $27.13 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $26.93 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | $33.70 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $33.81 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $33.96 10-K · filed 2023-02-27 | |||
| 2022-09-30 | $34.54 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $30.96 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | $33.10 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $25.71 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $24.66 10-Q · filed 2021-10-28 | |||
| 2021-06-30 | $24.74 10-Q · filed 2021-07-29 | |||
| 2021-03-31 | $22.59 10-Q · filed 2021-05-05 | |||
| 2020-12-31 | $19.18 10-K · filed 2021-02-24 | |||
| 2020-09-30 | $16.97 10-Q · filed 2020-10-29 | |||
| 2020-06-30 | $14.58 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $4.76 10-Q · filed 2020-04-30 | |||
| 2019-12-31 | $6.45 10-K · filed 2020-02-28 | |||
| 2019-09-30 | $3.86 10-Q · filed 2019-10-31 | |||
| 2019-06-30 | $3.86 10-Q · filed 2019-08-01 | |||
| 2019-03-31 | $4.37 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $3.51 10-K · filed 2019-03-06 | |||
| 2018-09-30 | $3.55 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | $3.55 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | $3.55 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | $5.81 10-K · filed 2018-03-22 | |||
| 2017-09-30 | $4.96 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | $7.04 10-Q · filed 2017-08-11 | |||
| 2017-03-31 | $6.75 10-Q · filed 2017-06-09 | |||
| 2016-12-31 | $8.88 10-K · filed 2018-03-22 | |||
| 2016-03-31 | $5.00 10-Q · filed 2016-05-16 | |||
| 2015-12-31 | $10.36 10-K · filed 2018-03-22 | |||
| 2014-12-31 | $2.74 10-K · filed 2017-04-21 | |||
| 2014-09-30 | $2.85 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | $2.96 10-Q · filed 2014-08-28 | |||
| 2013-12-31 | $4.73 10-K · filed 2016-03-29 | |||
| 2012-12-31 | $3.49 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |